Aminolysis of meso-Epoxides
FULL PAPER
+
HRMS (ESI): calcd for C16
H
28NO: 250.21654; found: 250.21657 [M+H] .
(p-chlorophenyl)ethane oxide (1l) (66 mg, 0.25 mmol) was added. The re-
sulting solution was stirred for 5 min, then aniline (46 mL, 0.50 mmol) was
added. After 1 d of stirring, the solvent was evaporated. The product was
purified by flash column chromatography over silica gel (diethyl ether/
petroleum ether 1:4) affording 4l as a pale-yellowviscous oil (83 mg,
The enantiomeric assay: Chiralcel OD, isocratic (n-hexane/iPrOH 95:5,
ꢀ
1
flow0.8 mLmin
9% ee.
(2R,3R)-1,4-Diphenyl-3-N-phenylamino-2-butanol (4h): Following gener-
) l=247 nm, (3R,4R): 8.3 min; (3S,4S): 10.5 min;
4
ACHTREUNG
2
5
al procedure IV, cis-dibenzyloxirane (1h) (112 mg, 0.50 mmol) was treat-
ed with aniline (91 mL, 1.00 mmol) at 08C. Flash chromatography (diethyl
ether/petroleum ether 2:3) afforded 4h as a pale-yellowviscous oil
93%). R
1.26 in CH
f
=0.31 (diethyl ether/petroleum ether 1:2); [a]
D
=+34.38 (c=
1
2
Cl
2
); H NMR (400 MHz, CDCl
3
): d=2.62 (brs, 1H; NH),
4.28 brs, 1H; OH), 4.44 (d, J=6.5 Hz, 1H; CH), 4.78 (d, J=6.5 Hz, 1H;
2
5
(
78 mg, 49%). R
f
=0.21 (diethyl ether/petroleum ether 1:3); [a] =+
CH), 6.50–6.52 (m, 2H; ArH), 6.67–6.71 (m, 1H; ArH), 7.06–7.17 (m,
D
1
13
1
1
1
1.48 (c=0.91 in CH
H; NH), 2.81–3.02 (m, 4H; CH
2
Cl
2
); H NMR (300 MHz, CDCl
3
): d=1.78 (brs,
), 3.62–3.67 (m 1H; CH), 3.90–3.95 (m,
H; CH), 4.14 (brs, 1H; OH), 6.66–6.76 (m, 3H; PhH), 7.13–7.32 ppm
6H; ArH), 7.22–7.27 ppm (m, 4H; ArH); C NMR (100 MHz, CDCl
3
):
d=64.27, 77.35, 114.2, 118.4, 128.0, 128.5, 128.6, 128.8, 129.1, 133.3, 133.8,
138.4, 138.8, 146.7 ppm; IR (film): n˜ =3400, 3052, 3026, 2923, 1601, 1489,
2
1
3
(
m, 12H; PhH); C NMR (75 MHz, CDCl
1.96, 113.4, 117.3, 126.3, 126.5, 128.5, 128.6, 129.2, 129.3, 129.4, 138.1,
38.6 ppm; IR (film): n˜ =3564, 3406, 3083, 3058, 3025, 2853, 1600, 1504,
3
): d=37.63, 40.84, 57.18,
1431, 1316, 1091, 1013, 834, 752, 733, 692 cm; UV/Vis (CH
3
CN): lmax (lg
7
1
1
2
2
e)=202 (4.339), 209 (4.303), 224 (4.372), 243 (4.220), 292 nm (3.490); MS
+
+
(ESI): m/z: 380.0 [M+Na] , 358.0 [M+H] ; HRMS (ESI): calcd for
ꢀ
1
+
391, 746 cm ; UV/Vis (CH
3
CN): lmax (lg e)=212 (4.223), 253 (4.244),
98 nm (3.419); MS (70 eV, EI): m/z (%): 317 (3) [M] , 299 (2), 252 (4),
26 (91), 196 (93), 104 (100), 91 (100), 77 (99); the enantiomeric assay:
Chiralcel OD, isocratic (n-hexane/iPrOH 90:10, flow0.8 mLmin ) l=
47 nm, (1R,2R): 13.2 min; (1S,2S): 15.5 min; 44% ee.
(1R,2R)-1,2-Bis(2’-naphthyl)-2-(phenylamino)ethanol (4i): A solution of
Sc(OTf) (8 mg, 10 mol%) and chiral bipyridine 2 (7 mg, 12 mol%) in di-
C H Cl NO: 358.07600; found: 358.07612 [M+H] ; the enantiomeric
2
0
18
2
+
assay: Chiralcel OD, isocratic (n-hexane/iPrOH 85:15, flow:
ꢀ
1
1.0 mLmin ) l=209 nm, (1R,2R): 15.8 min; (1S,2S): 23.6 min; 92% ee.
ꢀ1
[35]
A
H
R
U
G
(14): Following
2
general procedure IV, cis-stilbene oxide (1a) (98 mg, 0.50 mmol) was
treated with p-chloro aniline (128 mg, 1.00 mmol) at RT. Flash chroma-
tography (diethyl ether/petroleum ether 1:2) afforded 14 as a pale-yellow
ACHTREUNG
A
C
H
T
R
E
U
N
G
3
chloromethane (1 mL) was stirred for 10 min at RT. Then cis-1,2-bis(2’-
naphthyl)ethane oxide (1i) (50.0 mg, 0.17 mmol) was added. The result-
ing solution was stirred for 5 min, then aniline (31 mL, 0.34 mmol) was
added. After 8 h of stirring the solvent was evaporated. The product was
purified by flash column chromatography over silica gel (dichlorome-
thane/petroleum ether 9:1), affording 4i as a white solid (50 mg, 76%).
viscous oil (153 mg, 95%). R
f
=0.29 (diethyl ether/petroleum ether 1:2);
23
1
[
a]D =+34.28 (c=1.09 in CH
2
Cl
2
); H NMR (300 MHz, CDCl
3
): d=2.43
(
brs, 1H; NH), 4.48 (d, J=5.5 Hz; CH), 4.75 (brs, 1H; OH); 4.87 (d, J=
5
7
1
.5 Hz; CH), 6.43 (d, J=9.0 Hz; ArH), 7.00 (d, J=9.0 Hz; ArH), 7.19–
.31 ppm (m, 10H; ArH); C NMR (75 MHz, CDCl
15.1, 122.4, 126.4, 127.2, 127.6, 128.0, 128.3, 128.6, 128.8, 139.7, 140.4,
13
3
): d=64.62, 77.92,
2
3
R
f
=0.37 (CH
2
Cl
2
); m.p. 147–1508C; [a] =+109.48 (c=0.89 in CH
2
Cl
2
);
D
146 ppm; IR (film in CCl ): n˜ =3405, 3063, 3030, 2888, 1599, 1497, 1454,
4
1
H NMR (300 MHz, CDCl
3
): d=2.80 (brs, 1H; NH), 4.84 (d, J=5.5 Hz,
ꢀ1
1
2
3
315, 816, 788, 766, 700 cm ; UV/Vis (CH
3
CN): lmax (lg e)=202 (4.331),
2
7
7
H; CH, OH), 5.13 (d, J=5.5 Hz, 1H; CH), 6.58–6.7 (m, 3H; ArH),
+
10 (4.366), 255 (4.399), 306 nm (3.464); Ms (ESI): m/z: 346.0 [M+Na] ,
24.1 [M+H] ; the enantiomeric assay: Chiralcel OD, isocratic (n-
.04–7.11 (m, 2H; ArH), 7.38 (ddd, J=8.5, 6.5, 2.0 Hz, 2H; ArH), 7.44–
+
1
3
.53 (m, 4H; ArH), 7.74–7.85 ppm (m, 8H; ArH); C NMR (75 MHz,
): d=64.7, 78.0, 114.3, 118.1, 124.5, 125.4, 125.7, 126.0, 126.1, 126.2,
26.3, 126.3, 127.8, 128.1, 128.2, 128.5, 129.2, 133.1, 133.2, 133.2, 133.5,
37.9, 138.1, 147.3 ppm; IR (KBr): n˜ =3415, 3053, 2924, 1600, 1502,
ꢀ1
hexane/iPrOH 85:15, flow1.0 mLmin ) l=247 nm, (1S,2S): 15.7 min;
CDCl
3
(
1R,2R): 17.7 min. 95% ee.
1
1
7
[
35]
AHCTREUNG
(1R,2R)-2-(4-Methylphenylamino)-1,2-diphenylethanol (15): Following
ꢀ
1
general procedure IV, cis-stilbene oxide (1a) (98 mg, 0.50 mmol) was
treated with p-toluidine (107 mg, 1.00 mmol) at RT. Flash chromatogra-
phy (diethyl ether/petroleum ether 1:3) afforded 15 as a solid (153 mg,
3
50 cm ; UV/Vis (CH CN): lmax (lg e)=203 (4.417), 230 (4.603), 350 nm
(
(
3
2.504); MS (70 eV, EI): m/z (%): 371 (2), 267 (1), 232 (100), 155 (5), 127
+
+
6), 104 (23), 77 (22); MS (ESI): m/z: 801.3 [2M+Na] , 412.2 [M+Na] ,
+
95%). R =0.25 (diethyl ether/petroleum ether 1:3); m.p. 83–868C;
90.2 [M+H] ; HRMS (ESI): calcd for C28
H
24NO: 412.16719; found:
f
2
5
1
+
D
2 2 3
[a] =+31.48 (c=1.54 in CH Cl ); H NMR (300 MHz, CDCl ): d=2.20
4
12.16698 [M+H] ; the enantiomeric assay: Chiralcel OD, isocratic (n-
ꢀ
1
3
(s, 3H; CH ), 2.61 (brs, 1H; NH), 4.48 (brd, J=6.0 Hz, 2H; CH, OH),
hexane/iPrOH 90:10, flow: 0.8 mLmin ) l=227 nm, (1S,2S): 31.9 min;
1R,2R): 38.7 min; 82% ee.
(1R,2R)-2-(Phenylamino)-1,2-bis
(OTf) (11 mg, 10 mol%) and chiral bipyridine 2 (9 mg, 12 mol%) in di-
4
8
.84 (d, J=6.0 Hz, 1H; CH), 6.46 (d, J=8.0 Hz, 2H; ArH), 6.87 (d, J=
.0 Hz, 2H; ArH), 7.20–7.25 ppm (m, 10H; ArH);
(
1
3
C NMR
A
C
H
T
R
E
U
N
G
A
H
R
U
G
(
75 MHz,CDCl
3
): d=20.32, 65.18, 78.03, 114.3, 126.6, 127.2, 127.3, 127.4,
A
C
H
T
R
E
U
N
G
3
1
3
6
27.8, 128.2, 128.5, 129.5, 140.2, 140.5, 144.9 ppm; IR (KBr): n˜ =3611,
chloromethane (1 mL) was stirred for 5 min at RT. Then cis-1,2-bis-(m-
tolyl)ethane oxide (1k) (50 mg, 0.22 mmol) was added. The resulting so-
lution was stirred for 5 min, then aniline (40 mL, 0.44 mmol) was added.
After 7 h of stirring the solvent was evaporated. The product was purified
by flash column chromatography over silica gel (diethyl ether/petroleum
390, 3061, 3026, 2871, 1815, 1519, 1454, 1317, 1260, 1038, 1022, 805, 766,
ꢀ
1
3
97 cm ; UV/Vis (CH CN): lmax (lg e)=205 (4.336), 215 (4.316), 251
+
(
4.313), 281 nm (3.699); MS (ESI): m/z: 304.1 [M+H] ; the enantiomeric
ꢀ
1
assay: Chiralcel OD, isocratic (n-hexane/iPrOH 94:6, flow: 0.8 mLmin
l=247 nm, (1S,2S): 37.9 min; (1R,2R): 40.2 min; 87% ee.
)
ether 1:4), affording 4k as a pale-yellowviscous oil (65 mg, 93%).
f
R =
2
3
[35]
0
CH
CH
.3 (diethyl ether/petroleum ether 1:2); [a] =+50.28 (c=0.89 in
A
H
R
U
G
(16): Follow-
D
1
Cl
2
); H NMR (300 MHz, CDCl
3
): d=2.33 (s, 3H; CH
3
), 2.36 (s, 3H;
ing general procedure IV, cis-stilbene oxide (1a) (98 mg, 0.50 mmol) was
treated with p-anisidine (123 mg, 1.00 mmol) at 08C. Flash chromatogra-
phy (diethyl ether/petroleum ether 1:3) afforded 16 as a brown solid
2
3
), 2.57 (brs, 1H; NH), 4.52 (d, J=5.0 Hz, 1H; CH), 4.68 (brs, 1H;
OH), 4.86 (d, J=5.0 Hz, 1H; CH), 6.57 (dd, J=8.5, 1.0 Hz, 2H; ArH),
6
.69 (dd, J=7.5, 7.5 Hz, 1H; ArH), 7.07–7.24 ppm (m, 10H; ArH);
(139 mg, 87%). R
958C; [a]D =+25.18 (c=0.61 in CH Cl ); H NMR (200 MHz, CDCl ):
f
=0.4 (diethyl ether/petroleum ether 1:1); m.p. 91–
1
3
23
1
C NMR (75 MHz,CDCl
3
): d=21.5, 21.6, 54.6, 78.0, 114.1, 117.8, 123.6,
2
2
3
1
1
7
28.0, 128.2, 128.4, 128.5, 128.6, 129.1, 137.9, 138.2, 140.4, 140.6,
d=3.66 (s, 3H; OCH ), 4.40 (d, J=6.5 Hz, 1H; CH), 4.81 (d, J=6.5 Hz,
3
47.5 ppm; IR (film): n˜ =3398, 3024, 2920, 1601, 1502, 1313, 1105,
1H; CH), 6.51 (d, J=9.0 Hz, 2H; ArH), 6.66 ppm (d, J=9.0 Hz, 1H;
ꢀ
1
13
94 cm ; UV/Vis (CH
3
CN): lmax (lg e)=212 (4.262), 248 (4.144), 295 nm
ArH), 7.17–7.25 (m, 10H; ArH); C NMR (75 MHz, CDCl ): d=55.8,
3
+
+
(
3.292); MS (ESI): m/z: 657.3 [2M+Na] , 340.2 [M+Na] , 318.2
66.3, 78.2, 114.8, 115.9, 126.8, 127.5, 127.9, 128.2, 128.5, 140.3, 140.7,
+
[
M+H] ; HRMS (ESI): calcd for
C
22
H
23NaNO: 340.16719; found:
141.4 ppm; IR (KBr): n˜ =3479, 3428, 3027, 2933, 2831, 1807, 1510, 1452,
+
ꢀ1
3
40.16711 [M+Na] ; the enantiomeric assay: Chiralcel OD, isocratic (n-
1240, 1030, 820, 762, 698 cm ; UV/Vis (CH CN): l (lg e)=200 (4.139),
3
max
ꢀ
1
hexane/iPrOH 90:10, flow: 0.8 mLmin ) l=199 nm, (1R,2R): 15.9 min;
1S,2S): 21.1 min; 91% ee.
(1R,2R)-1,2-Di(p-chlorophenyl)-2-(phenylamino)ethanol (4l): A solution
of Sc(OTf) (12 mg, 10 mol%) and chiral bipyridine 2 (10 mg, 12 mol%)
in dichloromethane (1 mL) was stirred for 5 min at RT. Then cis-1,2-bis-
208 (4.250), 246 (4.072), 314 nm (3.403); MS (70 eV, EI): m/z (%): 319
+
(
(
1) [M] , 301 (1), 212 (100), 168 (8), 134 (10), 91 (5), 77 (9); MS (ESI):
+ + +
A
C
H
T
R
E
U
N
G
m/z: 661.3 [2M+Na] , 342.1 [M+Na] , 320.2 [M+H] ; the enantiomeric
assay: Chiralcel OD, isocratic (n-hexane/iPrOH 90:10, flow:
0.8 mLmin ) l=243 nm, (1S,2S): 31.9 min; (1R,2R): 38.7 min; 90% ee.
A
C
H
T
R
E
U
N
G
3
ꢀ
1
Chem. Eur. J. 2007, 13, 2729 – 2741
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2739